Telos Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.76M | Buy |
2,302
+1
| +0% | +$1.02K | 0.24% | 90 |
|
|
2026
Q1 | $2.12M | Sell |
2,301
-30
| -1% | -$30.4K | 0.2% | 89 |
|
|
2025
Q4 | $2.51M | Sell |
2,331
-154
| -6% | -$147K | 0.23% | 92 |
|
|
2025
Q3 | $1.9M | Sell |
2,485
-795
| -24% | -$592K | 0.18% | 95 |
|
|
2025
Q2 | $2.56M | Buy |
3,280
+1,298
| +65% | +$1.01M | 0.26% | 91 |
|
|
2025
Q1 | $1.64M | Sell |
1,982
-5
| -0.3% | -$4.16K | 0.18% | 98 |
|
|
2024
Q4 | $1.53M | Buy |
1,987
+371
| +23% | +$307K | 0.16% | 99 |
|
|
2024
Q3 | $1.43M | Hold |
1,616
| – | – | 0.15% | 105 |
|
|
2024
Q2 | $1.46M | Sell |
1,616
-70
| -4% | -$56K | 0.16% | 97 |
|
|
2024
Q1 | $1.31M | Sell |
1,686
-3,855
| -70% | -$2.74M | 0.15% | 104 |
|
|
2023
Q4 | $3.23M | Sell |
5,541
-160
| -3% | -$93.4K | 0.39% | 76 |
|
|
2023
Q3 | $3.06M | Hold |
5,701
| – | – | 0.43% | 72 |
|
|
2023
Q2 | $2.67M | Sell |
5,701
-159
| -3% | -$66.7K | 0.36% | 79 |
|
|
2023
Q1 | $2.01M | Sell |
5,860
-5
| -0.1% | -$1.69K | 0.28% | 87 |
|
|
2022
Q4 | $2.15M | Sell |
5,865
-177
| -3% | -$62.8K | 0.31% | 88 |
|
|
2022
Q3 | $1.95M | Sell |
6,042
-1,125
| -16% | -$356K | 0.32% | 86 |
|
|
2022
Q2 | $2.32M | Hold |
7,167
| – | – | 0.36% | 85 |
|
|
2022
Q1 | $2.05M | Sell |
7,167
-100
| -1% | -$25.7K | 0.27% | 93 |
|
|
2021
Q4 | $2.01M | Sell |
7,267
-100
| -1% | -$25.4K | 0.25% | 90 |
|
|
2021
Q3 | $1.7M | Hold |
7,367
| – | – | 0.23% | 99 |
|
|
2021
Q2 | $1.69M | Sell |
7,367
-1,735
| -19% | -$349K | 0.22% | 101 |
|
|
2021
Q1 | $1.7M | Buy |
9,102
+160
| +2% | +$31.3K | 0.24% | 98 |
|
|
2020
Q4 | $1.51M | Buy |
8,942
+40
| +0.4% | +$5.97K | 0.23% | 97 |
|
|
2020
Q3 | $1.32M | Hold |
8,902
| – | – | 0.23% | 95 |
|
|
2020
Q2 | $1.46M | Sell |
8,902
-50
| -0.6% | -$7.67K | 0.28% | 91 |
|
|
2020
Q1 | $1.24M | Buy |
8,952
+5,638
| +170% | +$775K | 0.31% | 91 |
|
|
2019
Q4 | $436K | Buy |
3,314
+250
| +8% | +$29K | 0.1% | 132 |
|
|
2019
Q3 | $343K | Buy |
3,064
+883
| +40% | +$98.3K | 0.09% | 135 |
|
|
2019
Q2 | $242K | Sell |
2,181
-80
| -4% | -$9.42K | 0.07% | 143 |
|
|
2019
Q1 | $293K | Sell |
2,261
-125
| -5% | -$15.2K | 0.09% | 128 |
|
|
2018
Q4 | $276K | Buy |
2,386
+191
| +9% | +$21.3K | 0.1% | 126 |
|
|
2018
Q3 | $236K | Sell |
2,195
-300
| -12% | -$30K | 0.08% | 146 |
|
|
2018
Q2 | $213K | Buy |
+2,495
| New | +$205K | 0.07% | 146 |
|
Other funds holding LLY
Telos Capital Management's LLY Position: Q2 2026 in Review
Telos Capital Management increased its Eli Lilly (LLY) stake by 0.04% in Q2 2026, buying an estimated $1.02K and bringing the position to 2,302 shares worth $2.76M. The position accounts for 0.24% of the portfolio, ranked #90.
Telos Capital Management first reported a position in LLY in Q2 2018 and has held it in 33 quarters since. The position peaked at $3.23M in Q4 2023. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Telos Capital Management held 2,302 shares of Eli Lilly worth $2.76M as of Q2 2026.
- Telos Capital Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
- Eli Lilly made up 0.24% of Telos Capital Management's portfolio in Q2 2026, its #90 holding.
- Telos Capital Management first reported a position in Eli Lilly in Q2 2018 and has held it in 33 quarters since.
- Telos Capital Management's Eli Lilly position peaked at $3.23M in Q4 2023.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.